Abstract:Introduction: Establishing a diagnosis is paramount in medical practice as it shapes patients' experiences and guides treatment. Patients grappling with rare diseases face a triple challenge: prolonged diagnostic journeys, limited responses to existing therapies, and the absence of effective monitoring tools. Genetic diagnosis often provides crucial diagnostic and prognostic information, opening up possibilities for genotype-targeted treatments and facilitating counselling and relative testing. The NIHR BioResource - Rare Diseases (NBR) Study and the Cohort Study in Idiopathic and Hereditary Pulmonary Arterial Hypertension (PAH Cohort study) aimed to enhance diagnosis and treatment for PAH, successfully identifying the genetic cause in 25% of idiopathic cases. However, the diagnostic and therapeutic odyssey in patients with PAH remains largely unexplored. Methods: Stakeholders from the NBR and PAH Cohort studies were recruited using purposive sampling. In-depth interviews and focus groups were recorded, transcribed, anonymised, and analysed thematically using MAXQDA software. Results: The study involved 53 interviews and focus groups with 63 participants, revealing key themes across five stages of the diagnostic odyssey: initial health concerns and interactions with general practitioners, experiences of misdiagnosis, relief upon receiving the correct diagnosis, and mixed emotions regarding genetic results and the challenges of living with the disease. Following the diagnosis, participants embarked on a therapeutic journey, facing various challenges, including the disease's impact on professional and social lives, the learning curve associated with understanding the disease, shifts in communication dynamics with healthcare providers, therapeutic hurdles, and insurance-related issues. Building on these insights, we identified areas of unmet needs, such as improved collaboration with primary care providers and local hospitals, the provision of psychological support and counselling, and the necessity for ongoing patient education in the ever-evolving realms of research and therapy. Conclusions: The study highlights the significant challenges encountered throughout the diagnostic and therapeutic journey in PAH. To enhance patient outcomes, it is crucial to raise awareness of the disease, establish clear diagnostic pathways, and seamlessly integrate genetic diagnostics into clinical practice. Streamlining the diagnostic process can be achieved by utilising existing clinical infrastructure to support research and fostering better communication within the NHS. Moreover, there is an urgent need for more effective therapies alongside less burdensome drug delivery methods.

Understanding what drives genetic study participation: Perspectives of patients, carers, and relatives

Unlocking the potential of genetic research in pulmonary arterial hypertension: Insights from clinicians, researchers, and study team

Gathering the Stakeholder's Perspective: Experiences and Opportunities in Rare Genetic Disease Research

Research participant perceptions of personal utility in disclosure of individual research results from genomic analysis

Genetic literacy and attitude towards genetic testing in patients with Parkinson's disease and their caregivers: A review of literature

Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews

Beliefs and attitudes towards participating in genetic research - a population based cross-sectional study

Genetics and precision genomics approaches to pulmonary hypertension

Secondary use of genomic data: patients' decisions at point of testing and perspectives to inform international data sharing

Global Perspectives on Returning Genetic Research Results in Parkinson's Disease

Parents' and patients' perspectives, experiences, and preferences for germline genetic or genomic testing of children with cancer: A systematic review

Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study

Genetic testing in psychiatry, the perceptions of healthcare workers and patients: a mini review

Participant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation

Patient perceptions of genetic counselors' role and emotional support needs in adults with Parkinson's disease

Associations between self-referral and health behavior responses to genetic risk information

Experiences across a genetic screening and testing programme pathway: a qualitative study of mammogram patient perspectives

Genetic Research: The Role of Citizens, Public Health and International Stakeholders

Publics' knowledge of, attitude to and motivation towards health-related genomics: a scoping review

Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study

A Randomized Trial of Two Remote Healthcare Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study